Cancer News

REGN5458 Trial Shows Promise in Relapsed/Refractory Multiple Myeloma

Apr 4, 2023 11:31:40 AM / by Naresh Bumma, MD posted in ASH, Multiple Myeloma

0 Comments

REGN5458: A Trial for Relapsed/Refractory Multiple Myeloma a BCMAxCD3 Bispecific Antibody Naresh Bumma MD - Synopsis below extracted from the video transcript.

 

Read More

Subscribe to Email Updates

Recent Posts